Revvity Inc (RVTY)
126.06
-0.28
(-0.22%)
USD |
NYSE |
Sep 27, 16:00
126.02
-0.04
(-0.03%)
After-Hours: 20:00
Revvity SG&A Expense (TTM): 1.019B for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 1.019B |
March 31, 2024 | 1.034B |
December 31, 2023 | 1.023B |
September 30, 2023 | 1.015B |
June 30, 2023 | 1.007B |
March 31, 2023 | 998.44M |
December 31, 2022 | 1.023B |
September 30, 2022 | 1.073B |
June 30, 2022 | 1.106B |
March 31, 2022 | 1.127B |
December 31, 2021 | 1.103B |
September 30, 2021 | 870.72M |
June 30, 2021 | 820.10M |
March 31, 2021 | 759.31M |
December 31, 2020 | 716.46M |
September 30, 2020 | 865.58M |
June 30, 2020 | 844.50M |
March 31, 2020 | 825.03M |
December 31, 2019 | 815.32M |
September 30, 2019 | 815.12M |
June 30, 2019 | 807.72M |
March 31, 2019 | 811.04M |
December 31, 2018 | 811.91M |
September 30, 2018 | 777.75M |
June 30, 2018 | 733.76M |
Date | Value |
---|---|
March 31, 2018 | 678.74M |
December 31, 2017 | 626.02M |
September 30, 2017 | 602.02M |
June 30, 2017 | 591.85M |
March 31, 2017 | 592.94M |
December 31, 2016 | 590.47M |
September 30, 2016 | 584.97M |
June 30, 2016 | 590.09M |
March 31, 2016 | 585.88M |
December 31, 2015 | 587.22M |
September 30, 2015 | 645.86M |
June 30, 2015 | 641.13M |
March 31, 2015 | 641.64M |
December 31, 2014 | 648.21M |
September 30, 2014 | 583.57M |
June 30, 2014 | 583.35M |
March 31, 2014 | 583.90M |
December 31, 2013 | 582.96M |
September 30, 2013 | 617.42M |
June 30, 2013 | 620.08M |
March 31, 2013 | 622.02M |
December 31, 2012 | 627.37M |
September 30, 2012 | 672.20M |
June 30, 2012 | 659.88M |
March 31, 2012 | 648.55M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
716.46M
Minimum
Dec 2020
1.127B
Maximum
Mar 2022
942.96M
Average
1.003B
Median
SG&A Expense (TTM) Benchmarks
Avantor Inc | 1.585B |
Agilent Technologies Inc | 1.564B |
Bionano Genomics Inc | 71.68M |
Bruker Corp | 805.40M |
Azenta Inc | 305.65M |